ESWI's sponsors
To finance its activities and plans, ESWI receives equal annual grants from ten pharmaceutical companies. Its scientific independence, however, is absolute and indisputable, as it is explicitly included in the group’s constitution. In addition, ESWI’s code of practice, signed by all sponsoring partners, stipulates that company representatives play an advising, never a deciding, role in the group.
The pharmaceutical companies supporting ESWI include:
- Baxter Vaccines
- Crucell
- Novartis
- Hofmann-La Roche
- Medimmune
- Nobilon
- Sanofi Pasteur MSD
- GlaxoSmithKline
- Solvay Pharmaceuticals
- Sanofi Pasteur
Manufacturers of influenza vaccines join forces in (European Vaccine Manufacturers) in order to promote a favourable climate for expanded vaccine protection and improved vaccine coverage in Europe. Manufacturers of influenza vaccines are assembled in the Influenza Vaccine Supply international task force to assist business leaders in ensuring adequate flu vaccine production capacity in the event of a pandemic, and to provide advice to health authorities regarding vaccination recommendations and delivery strategies.
No exclusive rights to sponsorship exist. ESWI is pleased to discuss sponsorship opportunities with any organisation (commercial, non-profit, educational) interested in supporting and facilitating its long-term objectives. Donations to individual projects, rather than general financial sponsorship, are also accepted and donors receive public acknowledgement of their support. Potential sponsors and/or donors are invited to contact the ESWI management: info@linkinc.be
ESWI proudly presents its Q&A Book on Influenza. 101 Questions and Answers on Influenza is a major work of reference for anyone with an interest in flu.
